The report highlights the AACR’s progress over the past year in support of our mission.
AACR CEO Margaret Foti Honored With Ovarcome Excellence Award
American Association for Cancer Research Returns as Charity Title Partner of Rock ‘n’ Roll Philadelphia Half Marathon
Investigational CDK4/6 Inhibitor Abemaciclib is Active Against a Range of Cancer Types
A Liquid Biopsy–based Test to Detect BRAF V600 Mutations in Advanced Cancers is Comparable to Standard Invasive Tests
Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival, Sept. 25-28, 2016
AACR Conference on The Science of Cancer Health Disparities, Sept. 25-28, 2016
San Antonio Breast Cancer Symposium, Dec. 6-10, 2016
AACR Annual Meeting 2017, April 1-5, 2017
This Cancer Research Catalyst blog post tells the story of Aime Franco, PhD, who went from cancer survivor to cancer researcher.
FierceBiotech reports on the results of a phase I study of abemaciclib published in Cancer Discovery which underscores some of the reasons the FDA decided to hand it “breakthrough” status.